IP Library Assignment 070877/0696
Patent Assignment
Reel/Frame 070877/0696

Assignment of Assignor's Interest

Recorded: 2025-04-18 Pages: 10
Assignor
Assignee
AZURITY PHARMACEUTICALS, INC.
8 CABOT ROAD, SUITE 2000, WOBURN, MASSACHUSETTS, 0180
Covered Properties (45)
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 16/170,948 →
Publication: US 2019/0374462
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 16/176,866 →
Pharmaceutical Compositions of Testosterone
Application: 16/363,376 →
Publication: US 2019/0307772
Pharmaceutical Compositions of Meloxicam
Application: 16/371,293 →
Publication: US 2019/0307681
Pharmaceutical Compositions of Posaconazole
Application: 16/410,149 →
Publication: US 2020/0237753
Pharmaceutical Compositions of Lurasidone
Application: 16/697,415 →
Publication: US 2020/0222394
Pharmaceutical Compositions of Lurasidone
Application: 16/774,457 →
Publication: US 2020/0222395
Pharmaceutical Compositions of Nilotinib
Application: 16/793,833 →
Publication: US 2020/0261449
Pharmaceutical Compositions of Nilotinib
Application: 16/953,728 →
Publication: US 2021/0077485
Stable Pharmaceutical Compositions of Dihydroergotamine Mesylate
Application: 17/028,863 →
Publication: US 2021/0085657
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 17/386,139 →
Publication: US 2021/0369604
Pharmaceutical Compositions of Cabozantinib
Application: 17/673,583 →
Publication: US 2022/0265633
Pharmaceutical Compositions of Testosterone
Application: 17/696,319 →
Publication: US 2022/0202830
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Application: 17/822,399 →
Publication: US 2023/0086729
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Application: 17/822,756 →
Publication: US 2023/0091021
Pharmaceutical Compositions of Mifepristone
Application: 17/843,669 →
Publication: US 2023/0085008
Stable Pharmaceutical Compositions of Clonidine
Application: 17/866,115 →
Publication: US 2023/0149359
Stable Pharmaceutical Compositions of Bendamustine
Application: 17/877,476 →
Stable Pharmaceutical Compositions of Cyclophosphamide
Application: 17/961,943 →
Publication: US 2023/0119069
Stable Liquid Compositions of Netupitant and Palonosetron
Application: 18/069,204 →
Publication: US 2023/0190737
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 18/098,505 →
Publication: US 2023/0149294
Pharmaceutical Compositions of Cabozantinib
Application: 18/108,423 →
Publication: US 2023/0181561
Stable Pharmaceutical Compositions of Apixaban
Application: 18/117,808 →
Publication: US 2023/0285368
Stable Pharmaceutical Compositions of Hydroxyurea
Application: 18/163,811 →
Publication: US 2023/0301945
Stable Liquid Compositions of Glucagon
Application: 18/202,103 →
Publication: US 2023/0381282
Pharmaceutical Compositions of Testosterone
Application: 18/299,493 →
Publication: US 2023/0248742
Pharmaceutical Compositions of Cabozantinib
Application: 18/312,857 →
Publication: US 2023/0270736
Stable Pharmaceutical Compositions of Bendamustine
Application: 18/328,392 →
Publication: US 2023/0310384
Stable Pharmaceutical Compositions of Edaravone
Application: 18/340,067 →
Publication: US 2024/0285582
Stable Pharmaceutical Compositions of Apixaban
Application: 18/420,099 →
Publication: US 2024/0197705
Ready-To-Use Injectable Pharmaceutical Compositions Comprising Neostigmine and Glycopyrrolate
Application: 18/444,310 →
Publication: US 2024/0189222
Pharmaceutical Compositions of Nilotinib
Application: 18/468,266 →
Publication: US 2024/0009188
Stable Antiemetic Emulsions for Parenteral Administration
Application: 18/487,330 →
Publication: US 2024/0156829
Stable Pharmaceutical Compositions of Bendamustine
Application: 18/502,396 →
Publication: US 2024/0075014
Pharmaceutical Compositions of Cabozantinib
Application: 18/523,274 →
Publication: US 2024/0131018
Stable Pharmaceutical Compositions of Succinylcholine Chloride
Application: 18/528,684 →
Publication: US 2024/0108571
Pharmaceutical Compositions of Mifepristone
Application: 18/530,815 →
Publication: US 2024/0122944
Pharmaceutical Liquid Compositions of Meloxicam
Application: 18/542,163 →
Publication: US 2024/0139204
Stable Pharmaceutical Compositions of Bendamustine
Application: 18/758,225 →
Publication: US 2024/0350459
Stable Liquid Compositions of Netupitant and Palonosetron
Application: 18/794,778 →
Publication: US 2024/0390365
Stable Liquid Compositions of Glucagon
Application: 18/896,310 →
Publication: US 2025/0032586
Pharmaceutical Compositions of Cabozantinib
Application: 18/901,359 →
Publication: US 2025/0025456
Pharmaceutical Compositions of Mifepristone
Application: 18/904,225 →
Publication: US 2025/0057855
Pharmaceutical Compositions of Testosterone
Application: 18/911,778 →
Publication: US 2025/0032508
Stable Pharmaceutical Compositions of Cyclophosphamide
Application: 18/925,887 →
Publication: US 2025/0049824
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 26, 2018
From: BHISE, RAHUL DHULAJI; SINGH, AJAY KUMAR; MAHADIK, MAHADEO VASANT; DUBEWAR, ASHISH ANILRAO
To: SLAYBACK PHARMA LLC
Reel/Frame 047322/0911 →
Assignment of Assignor's Interest Oct 31, 2018
From: BHISE, RAHUL DHULAJI; SINGH, AJAY KUMAR; MAHADIK, MAHADEO VASANT; DUBEWAR, ASHISH ANILRAO
To: SLAYBACK PHARMA LLC
Reel/Frame 047373/0474 →
Assignment of Assignor's Interest Mar 25, 2019
From: SONI, UMANGI K.; SINGH, PREM PRAKASH; BAPATU, HANIMI REDDY; SUBBAPPA, PRAVEEN KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 048688/0760 →
Assignment of Assignor's Interest Apr 11, 2019
From: BHISE, RAHUL DHULAJI; DUBEWAR, ASHISH ANILRAO; MOLUGU, PRASHANTH REDDY
To: SLAYBACK PHARMA LLC
Reel/Frame 048857/0296 →
Assignment of Assignor's Interest May 13, 2019
From: JAIN, PARAS P.; JAIN, GIRISH KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 049157/0593 →
Assignment of Assignor's Interest Nov 27, 2019
From: JAIN, PARAS P.; SINGH, AJAY KUMAR; SUBBAPPA, PRAVEEN KUMAR; PRIYA, KEERTHI
To: SLAYBACK PHARMA LLC
Reel/Frame 051127/0293 →
Assignment of Assignor's Interest Feb 20, 2020
From: JAIN, PARAS P.; SINGH, AJAY KUMAR; PRIYA, KEERTHI; JAIN, GIRISH KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 051868/0974 →
Assignment of Assignor's Interest Jan 26, 2022
From: CHINNARI, HARISH GOVINDARAJA SETTY; BATTINI, SOMASHEKHAR; LOHAR, JAGDISH LOTAN
To: SLAYBACK PHARMA LLC
Reel/Frame 058777/0235 →
Assignment of Assignor's Interest Mar 3, 2022
From: DUBE, SUSHANT OMPRAKASH; SAOJI, SUPRIT DILIP; CHATKI, PANKAJ KISAN; PILLAI, SUMITRA ASHOKKUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 059156/0055 →
Assignment of Assignor's Interest Jul 7, 2022
From: JAIN, PARAS P.; NAVGIRE, SOMNATH DEVIDAS; PILLAI, SUMITRA ASHOKKUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 060430/0376 →
Assignment of Assignor's Interest May 26, 2023
From: CHINNARI, HARISH GOVINDARAJA SETTY; BATTINI, SOMASHEKHAR; PILLAI, SUMITRA ASHOKKUMAR; THIPPABATTUNI, LOURDU CHINNU
To: SLAYBACK PHARMA LLC
Reel/Frame 063777/0275 →
Assignment of Assignor's Interest Jun 5, 2023
From: CHARKHA, AMIT ANIL; PILLAI, SUMITRA ASHOKKUMAR; KARE, PRADEEP KUMAR; UMMITI, KUMAR SWAMY
To: SLAYBACK PHARMA LLC
Reel/Frame 063859/0754 →
Assignment of Assignor's Interest Jun 5, 2023
From: CHARKHA, AMIT ANIL; PILLAI, SUMITRA ASHOKKUMAR; KARE, PRADEEP KUMAR; UMMITI, KUMAR SWAMY
To: SLAYBACK PHARMA LLC
Reel/Frame 063859/0816 →
Assignment of Assignor's Interest Jun 6, 2023
From: MANDGE, SHAILENDRA; GUNDA, HARISH; KETHA, NAGA VENKATA DURGA PRASAD; KEESARA, VENKATESHWAR REDDY
To: SLAYBACK PHARMA LLC
Reel/Frame 063871/0167 →
Corrective Assignment to Correct the Assignment Document (Title) Previously Recorded on Reel 048688 Frame 0760. Assignor(S) Hereby Confirms the Assignment. Jun 13, 2023
From: SONI, UMANGI K.; SINGH, PREM PRAKASH; BAPATU, HANIMI REDDY; SUBBAPPA, PRAVEEN KUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 063988/0435 →
Security Interest Sep 27, 2023
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065045/0560 →
Release of Security Interest Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
Confirmatory Grant of Security Interest in United States Patents Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →